← Back to Search

Cool Room Treadmill Training for Multiple Sclerosis

N/A
Waitlist Available
Led By Michelle Ploughman, PhD
Research Sponsored by Memorial University of Newfoundland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged older than 18 and less than 70 years
People with a confirmed diagnosis of relapsing-remitting or progressive MS
Must not have
A relapse of MS
Functional community ambulators (gait speed>120 cm/s)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following completion of the 12-week exercise intervention and 3-months post-exercise intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how effective a more intense form of exercise is in people with MS who have fatigue and heat-sensitivity.

Who is the study for?
This trial is for people aged 18-70 with a confirmed diagnosis of relapsing-remitting or progressive Multiple Sclerosis. Participants should be stable without MS relapse for at least 90 days and able to walk at least 10 meters, even if they need walking aids.
What is being tested?
The study tests vigorous intensity treadmill training in a cool room (16°C) against low-intensity training to see which is better for restoring functions lost due to MS. The focus is on finding the right amount of exercise that can be tolerated by those who experience fatigue and heat sensitivity from MS.
What are the potential side effects?
Potential side effects may include muscle soreness, fatigue, and temporary worsening of MS symptoms due to physical exertion or reactions to cooler temperatures during the exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 69 years old.
Select...
I have been diagnosed with relapsing-remitting or progressive MS.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My MS has relapsed.
Select...
I can walk quickly without assistance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following completion of the 12-week exercise intervention and 3-months post-exercise intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and following completion of the 12-week exercise intervention and 3-months post-exercise intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fast walking speed
Secondary study objectives
Fatigue Severity Scale
Hospital Anxiety and Depression Scale
Maximal oxygen consumption during graded exercise test
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vigorous Intensity GroupExperimental Treatment1 Intervention
More than 60% Heart Rate Reserve
Group II: Low Intensity GroupActive Control1 Intervention
Less than 40% Heart Rate Reserve

Find a Location

Who is running the clinical trial?

Memorial University of NewfoundlandLead Sponsor
70 Previous Clinical Trials
1,835,969 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
62 Patients Enrolled for Multiple Sclerosis
Multiple Sclerosis Society of CanadaOTHER
15 Previous Clinical Trials
977 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
977 Patients Enrolled for Multiple Sclerosis
Michelle Ploughman, PhDPrincipal InvestigatorMemorial University of Newfoundland
1 Previous Clinical Trials
52 Total Patients Enrolled

Media Library

Body-weight supported treadmill training in a room cooled to 16°C Clinical Trial Eligibility Overview. Trial Name: NCT04175054 — N/A
Multiple Sclerosis Research Study Groups: Vigorous Intensity Group, Low Intensity Group
Multiple Sclerosis Clinical Trial 2023: Body-weight supported treadmill training in a room cooled to 16°C Highlights & Side Effects. Trial Name: NCT04175054 — N/A
Body-weight supported treadmill training in a room cooled to 16°C 2023 Treatment Timeline for Medical Study. Trial Name: NCT04175054 — N/A
~9 spots leftby Feb 2025